Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Renata R Urban

2PUBLICATIONS

13CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Mar 06, 2023

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.

Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber

|Jun 23, 2016

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers.

Jovana Y Martin, Renata R Urban, John B Liao

Pageof 1

Frequent Collaborators

2 joint publications

John B Liao

1 joint publications

Jovana Y Martin

1 joint publications

Talayeh S Ghezelayagh

1 joint publications

Emily S Wu

1 joint publications

Emma L Barber

1 joint publications

Minh D Dao

1 joint publications

Emese Zsiros

1 joint publications

Heidi J Gray

1 joint publications

Barbara A Goff

1 joint publications

Chirag A Shah

Frequent Collaborators

2 joint publications

John B Liao

1 joint publications

Jovana Y Martin

1 joint publications

Talayeh S Ghezelayagh

1 joint publications

Emily S Wu

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos